SEARCH · PubMed Health

Results for “Aflatoxin B1”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 235 records · Page 13Linked to original sources

PubMed1981

Implications of seasonal variations in aflatoxin B1 levels in Nigerian market foods.

Aflatoxin B1 levels were determined in Nigerian rural and urban market foods from 1977 to 1978. In general, levels were found to be highest during the peak rainy season, and the data suggest that livestock and humans are at highest risk from aflatoxicosis during this time. The incubation period for humans and nonhumans varies, and the risk to man from seasonal exposure to aflatoxin is assessed and reviewed. Primary hepatocellular carcinoma patients showed first symptoms of tumors during the dry season.

Aflatoxin B1↗

PubMed1988

Biosynthetic origin of aflatoxin G1: confirmation of sterigmatocystin and lack of confirmation of aflatoxin B1 as precursors.

The origin of aflatoxin G1 was studied using mutant strains of Aspergillus parasiticus blocked early in the pathway and by tracing 14C-labelled aflatoxin B1 (AFB1) in wild-type A. flavus and A. parasiticus strains. Sterigmatocystin (ST) was a precursor of AFB1, AFG1 and AFG2 in the four mutants examined. The identity of AFG1 was confirmed by mass spectrometry. No evidence for conversion of AFB1 to AFG1 was found. A rigorously controlled study of conversions of radioactivity based on preparative thin-layer chromatography of aflatoxins demonstrated that low levels of aflatoxin interconversions previously reported in the literature might actually be artifacts.

Aflatoxin B1↗

PubMedDate not supplied

Immunoaffinity column cleanup with liquid chromatography using post-column bromination for determination of aflatoxin B1 in cattle feed: collaborative study.

A collaborative study was conducted to evaluate the effectiveness of an immunoaffinity column cleanup liquid chromatography (LC) method for determination of aflatoxin B1 in cattle feed at a possible future European regulatory limit (1 ng/g). The test portion was extracted with acetone-water (85 + 15), filtered, diluted with water, and applied to an immunoaffinity column. The column was washed with water to remove interfering compounds, and the purified aflatoxin B1 was eluted with methanol. Aflatoxin B1 was separated and determined by reversed-phase liquid chromatography (RP-LC) and detected by fluorescence after post column derivatization (PCD) involving bromination. PCD was achieved with either pyridinium hydrobromide perbromide (PBPB), used by 14 laboratories, or an electrochemical cell and addition of bromide to the mobile phase, used by 7 laboratories. Both derivatization techniques were not significantly different when compared by the t-test; the method was statistically evaluated for all laboratories together (bromination and PBPB). The cattle feed samples, both spiked and naturally contaminated with aflatoxin B1, were sent to 21 laboratories in 14 different countries (United States, Japan, and Europe). Test portions were spiked at levels of 1.2 and 3.6 ng/g for aflatoxin B1. Recoveries ranged from 74 to 157%. Based on results for spiked samples (blind pairs at 2 levels) as well as naturally contaminated samples (blind pairs at 3 levels), the relative standard deviation for repeatability (RSDr) ranged from 5.9 to 8.7%. The relative standard deviation for reproducibility (RSDR) ranged from 17.5 to 19.6%. The method showed acceptable within- and between-laboratory precision for this matrix, as evidenced by HORRAT values, at the target levels of determination for aflatoxin B1. No major differences in RSD were observed, showing that the composition of the feeds was not a factor for the samples tested and that the method was applicable for all materials used.

Aflatoxin B1↗

PubMed2001

Methyl jasmonate stimulates aflatoxin B1 biosynthesis by Aspergillus parasiticus.

Aflatoxin B1 (AFB1) is a highly toxic and carcinogenic metabolite produced by certain Aspergillus species on agricultural commodities. One factor promoting the production of aflatoxin is the presence of high levels of fatty acid hydroperoxides often found in plant material under stress. Jasmonic acid (JA) and its methyl ester (MeJA) are derived from linolenic acid, and their biosyntheses involve the production of lipid hydroperoxides. Exposure of aflatoxigenic mold to jasmonates is likely because the mold attacks plant material and possibly initiates the production of jasmonates. In this study the effect of MeJA on the growth of Aspergillus parasiticus and AFB1 biosynthesis is reported. MeJA, at a final concentration of 10(-4) M in yeast extract sucrose medium, did not have any apparent effect on mycelial growth during the 16 days of observation but did increase significantly the levels of AFB1 after the seventh day of growth. After the ninth day, AFB1 production was decreased in contrast to the control cultures, where the production was constantly increasing. AFB1 determination was performed by immunoaffinity and HPLC after derivatization to AFB2a.

Acetates↗

PubMed1988

[Influence of aflatoxin B1 on growth of rats under various nutritional conditions].

The effect of the addition of aflatoxin B1 was studied in 48 male, Sprague-Dawley rats weaned at 21 days of age. The animals of the experimental group received one of the following diets to which aflatoxin B1 was added (5 mg/kg ration), a protein-free diet, the regional basic diet of Northeast Brazil (RBD) containing 9.07% protein, and commercial casein diets (at 10 and 20%). The control groups were fed the same diets without aflatoxin B1. To detect possible body alterations, the body weight and food intake, as well as protein and aflatoxin B1 intakes were recorded. Significant alterations were detected in the experimental groups, especially in the protein-depleted animals, and in those fed the RBD and 10% commercial casein diets, when compared to their controls.

Aflatoxin B1↗

PubMedDate not supplied

Acute toxicity of aflatoxin B1 and rubratoxin B in dogs.

The effect of ip administrated aflatoxin B1 and rubratoxin B, singly and in combination, on dogs was determined by serum tests, by observations of clinical signs and survival times, and by evaluation of gross and microscopic lesions. The dog is sensitive to the toxic effects of both mycotoxins. Glutamic-oxaloacetic transaminase, lactic dehydrogenase and alkaline phosphatase activities and survival time varied in relation to dose and to the mycotoxin(s) administered. All three plasma enzymes were elevated regardless of dose with the combination of aflatoxin B1/rubratoxin B at 24 hr after dosing, except LDH, which was within the normal range but only at the lowest dose level. Several serum constituents including BUN, cholesterol, uric acid, and total bilirubin were elevated, whereas serum glucose was depressed in dogs treated with the multiple-toxin regimen; these changes were not seen in dogs given only aflatoxin B1 but were characteristic in rubratoxin-treated animals. In general, gross findings at necropsy were similar in all dogs regardless of the dose regimen. A striking similarity existed in the histologic changes observed between lesions experimentally induced by the mycotoxin combination and those lesions reported for dogs fed toxic feed in laboratory studies or in natural cases of hepatitis X. Of particular similarity were the severe kidney lesions observed in dogs exposed to the mycotoxin combination and kidney lesions reported in natural outbreaks of hepatitis X. There can be little doubt of an association between hepatitis X and aflatoxin B1, although it is apparent that the disease probably involves more than a single toxic factor. Our results suggest that hepatitis X in dogs includes aflatoxin B1 as a primary etiological factor but that rubratoxin B also may be involved.

Aflatoxins↗

PubMed1988

Effect of nutritional factors on aflatoxin B1 inhibition of growth in Escherichia coli and Salmonella typhi.

The extent of growth inhibition by aflatoxin B1 in S. typhi and E. coli was greater in the presence of sodium citrate or sodium phosphate, palmitic and stearic acid than aflatoxin B1 alone. The addition of amino acids (glycine or glutamic acid) stimulated growth in E. coli and inhibited in S. typhi in the presence of aflatoxin B1. Other nutrients, such as yeast extract, lactose, or salt addition did not alter aflatoxin B1 antibacterial activity but decreased growth was observed in the presence of peptone.

Aflatoxin B1↗

PubMed1998

Genetic organization and function of the aflatoxin B1 biosynthetic genes.

Aflatoxins are secondary metabolites produced by Aspergillus flavus and Aspergillus parasiticus. Most of the genes involved in the biosynthesis of aflatoxin are contained within a single cluster in the genome of these filamentous fungi. Studies directed toward understanding the molecular biology of aflatoxin biosynthesis have led to a number of important discoveries. A pair of fatty acid synthase genes were identified that are involved uniquely in aflatoxin biosynthesis. Two genes were also characterized that represent new families of cytochrome P450 monooxygenases. Gene expression is coordinated during aflatoxin production and is under the control of a positive regulatory gene belonging to a family of fungal transcriptional activators associated with various metabolic pathways in fungi.

Aflatoxin B1↗

PubMed1984

Frequency of chromosome aberrations in bone marrow of monkeys and their F1 after aflatoxin B1 injection.

A mutagenic effect of aflatoxin B1 (AFB1) in somatic cells of primates is investigated. It is shown that AFB1 elevated the frequency of chromosome aberrations in the bone marrow of two species of monkeys: Macaca mulatta and Papio hamadryas. Beside chromosome aberrations, genome mutations were found in these experimental primates. AFB1-induced chromosome aberrations were constantly revealed during two years of study. Increase in the frequency of chromosome aberrations could be demonstrated in Macaca babies born from females that had received AFB1 at the final stage of pregnancy.

Aflatoxin B1↗

PubMed1986

The effect of schistosomiasis on the activation of aflatoxin B1.

This study examined activation of aflatoxin B1 (AFB1) in livers of Schistosoma mansoni-infected and noninfected mice by measuring covalent binding of [3H]AFB1 to cellular macromolecules in vivo and in vitro. During a one week time period after AFB1 treatment of animals, maximal binding of [3H]AFB1 to DNA, RNA and protein in liver occurred during the 1-6 hour period after treatment, with less binding throughout of AFB1 to macromolecules of infected mice. Experiments performed in vitro to determine the capacity of liver microsomes to mediate the binding of AFB1 to calf thymus DNA showed that microsomes from infected mice mediated the binding of less [3H]AFB1 to DNA than those from noninfected animals.

Aflatoxin B1↗

PubMed1991

Pharmacokinetics of intratracheally administered aflatoxin B1.

High concentrations of the carcinogen aflatoxin B1 (AFB1) are commonly found in respirable, airborne grain dusts, and inhaled AFB1 has been shown to be a risk factor for occupational pulmonary carcinogenesis. The fate of AFB1 exposure via the respiratory tract is therefore of interest in an evaluation of potential occupational risk. The pharmacokinetic disposition of intratracheally administered AFB1 was studied in male Sprague-Dawley rats. Blood and tissues were sampled at selected intervals for 3 weeks following administration of a single dose of grain dust-adsorbed or microcrystalline [3H]AFB1 (6 micro-Ci: microgramsg/kg). The blood concentration-time profiles from both groups best approximated a two-compartment open model with first-order absorption. The first-order absorption rate constant was significantly less in the animals given dust-adsorbed AFB1 than in those receiving microcrystalline AFB1 (0.083 vs -0.1060 min -1, respectively), although the first-order elimination rate constants for both groups were nearly identical (0.00928 and 0.00921 hr-1, respectively). Blood concentrations of the AFB1 metabolites AFM1, AFQ1, AFL, and AFP1 showed little differences among the two groups. The tissue concentrations of aflatoxins for the microcrystalline group were significantly greater at 3 hr in all tissues examined except for the trachea and lung in which those for the dust-adsorbed group were greater. At 3 days and 3 weeks, no significant differences between exposure groups were seen in any tissue except fat, where the amount of aflatoxins was greater for the dust-adsorbed group. AFB1 binding to DNA was significantly greater in the trachea and lung of the dust-adsorbed group compared to that in the microcrystalline group at 3 hr, whereas in the liver the AFB1-DNA binding in the microcrystalline group was significantly greater during this time. Thus, particle association of AFB1 increased the respiratory tract retention of this compound at early time intervals, which might be a factor in the reputed carcinogenic action of this compound in the respiratory tract. These findings may be useful as part of a comprehensive study to evaluate the disposition of AFB1 in individuals exposed to grain dusts laden with this carcinogen.

Absorption↗

PubMedDate not supplied

Picroliv protects against aflatoxin B1 acute hepatotoxicity in rats.

The hepatoprotective activity of Picroliv, a standardized iridoid glycoside fraction of Picrorhiza kurroa, has been investigated by studying the protection of biochemical and histological changes induced in livers of rats given single oral doses (7 mg/kg) of aflatoxin B1. Administration of aflatoxin B1 resulted in a significant increase in 5'-nucleotidase, r-glutamyl transpeptidase, acid ribonuclease, total lipids, cholesterol and lipid peroxides in liver and transaminases, alkaline phosphatase and bilirubin in serum. However, the activity of glucose 6-phosphatase and levels of cytochrome P450, cytochrome b5, DNA, RNA, proteins and glycogen in liver and total proteins in serum decreased. The liver histology showed ballooned hepatocytes, degeneration, microvesicular fat, focal necrosis, bile duct hyperplasia and proliferation of oval and spindle cells in portal tracts. When Picroliv (25 mg/kg x 7 days) was given to aflatoxin B1 toxicated rats, the majority of the biochemical and histological changes were significantly protected. The findings indicate a hepatoprotective activity of Picroliv against aflatoxin B1 toxicity in rats.

Aflatoxin B1↗

PubMed1984

Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes.

The hepatocarcinogen aflatoxin B1 (AFB1) was found to be a potent clastogen for phytohemagglutinin stimulated human lymphocytes. It also induced sister chromatid exchanges. These types of chromosomal damage were induced at very low levels of covalent AFB1 - DNA adducts suggesting that AFB1 operates in part by indirect action because of its membrane-active character. The membrane-active character of AFB1 is documented by the following results: (i) AFB1 stimulated the excretion of hydroxy- and/or hydroperoxy-arachidonic acid (AA) and free AA into the culture medium; (ii) the phospholipase A2 inhibitor p-bromophenacylbromide was anticlastogenic ; (iii) the inhibitors of the oxidative metabolism of AA indomethacin, flufenamic acid, 5,8,11,14-eicosatetraynoic acid, nordihydroguaiaretic acid and BN 1015 were anticlastogenic . These results are compatible with the induction of DNA damage by indirect action or the formation of covalent adducts via metabolic activation by cooxygenation . The observation that CuZn superoxide dismutase was anticlastogenic indicates the intermediacy of superoxide in DNA damage formation and supports the former mechanism.

Aflatoxin B1↗

PubMed1984

Effect of manipulation of gamma-glutamyl transpeptidase levels on biliary excretion of aflatoxin B1 conjugates.

The reactive intermediate of aflatoxin B1 (AFB1) forms a glutathione conjugate (AFB1-GSH) and this has been shown to be a substrate for gamma-glutamyl transpeptidase (GGT) in vitro. This study describes the biliary excretion of AFB1-GSH and the product of GGT activity, the cysteinylglycyl conjugate (AFB1-Cys-Gly), following i.v. injection of AFB1 (5 mumol kg-1) in control male rats and in rats that had been maintained on a toxic diet containing 4 p.p.m. AFB1 for 10-12 weeks prior to the experiment. AFB1 metabolites in the bile were analyzed by reverse phase h.p.l.c. and GGT activity in the liver was assessed histochemically and by quantitative fluorimetric assay. In the control male rats (n = 6) AFB1-GSH and AFB1-Cys-Gly together were detected as 4.2 +/- 2.3% of the i.v. dose over the first two hours of bile collection (AFB1-GSH:AFB1-Cys-Gly, 5.5:1). GGT activity (38.2 +/- 7.9 nmol product formed/g liver) was located in the bile duct epithelium. The group maintained on a toxic diet (n = 2) showed higher levels of AFB1-Cys-Gly (AFB1-GSH:AFB1-Cys-Gly, 1:1). GGT activity was elevated (5-10 x control levels) and located in numerous foci throughout the liver. The involvement of GGT in the biliary excretion of AFB1-Cys-Gly was demonstrated by in vivo inhibition of GGT by administering AT125 to a group of animals (n = 3) 15 min prior to the injection of AFB1. Histochemical and quantitative estimation of GGT confirmed total inhibition throughout the liver and conversion of AFB1-GSH to AFB1-Cys-Gly was almost completely blocked. Female Fischer 344 rats (n = 3) showed slightly elevated AFB1-Cys-Gly excretion and higher GGT activity (79.3 +/- 26.3 nmol/min/g liver) compared to control male rats.

Aflatoxin B1↗

PubMedDate not supplied

Determination of aflatoxicol and aflatoxins B1 and M1 in eggs.

Procedures from 2 methods, one for aflatoxins B1 and M1 in eggs and one for aflatoxicol in milk, blood, and liver, have been combined to determine the 3 toxins in eggs. The sample is blended with sodium chloride-saturated water and this mixture is then blended with acetone. After separation from the solid residue, the aqueous acetone extract is defatted with petroleum ether. The toxins are next partitioned into chloroform and separated from interferences on a silica gel column. Aflatoxicol is determined by fluorescence measurement after separation on a C18 reverse phase liquid chromatographic column, and aflatoxins B1 and M1 are determined by fluorescence densitometry after separation on a silica gel thin layer chromatographic plate. In a recovery study with eggs, mean recoveries of aflatoxicol added at levels of 0.1, 0.05, and 0.025 ng/g were 87, 77, and 78%, respectively. Mean recoveries of aflatoxins B1 and M1 added at a level of 0.1 ng/g were 75 and 87%, respectively, and at an added level of 0.05 ng/g were 86 and 75%. The within-laboratory precision (repeatability) ranged from 2 to 13%.

Aflatoxin B1↗

PubMed1979

Aflatoxin B1; its role in the etiology of Reye's syndrome.

Seven cases of Reye's syndrome in which aflatoxin B1 was isolated from the blood or liver or both are presented. In two cases aflatoxin B1 was found in the blood during the acute phase of the disease; a finding not previously reported. In six cases aflatoxin B1 was recovered from autopsy specimens of liver. A number of case reports linking aflatoxin B1 to Reye's syndrome have appeared in the literature but until now only one case had been reported from the United States. Aflatoxin B1 and its possible role in the etiology of Reye's syndrome is discussed. It is concluded that Reye's syndrome is the result of multiple interrelated factors.

Aflatoxins↗

PubMed1997

In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1.

Activation of ras proto-oncogenes occurs frequently in vivo in chemically induced rodent tumours, including rat hepatomas induced by aflatoxin B1. This study examines the in vitro activation of a human ras gene by this mycotoxin. A plasmid containing the human Ha-ras proto-oncogene, together with a neomycin resistance gene (pECneo), was incubated in vitro with a microsomal system generating aflatoxin B1 8,9-epoxide. Subsequent transfection of the plasmid into mouse NIH 3T3 fibroblasts, followed by G418 selection and s.c. injection of surviving cells into immunodeficient mice demonstrated that the proto-oncogene had acquired transforming capacity. Although a single tumour resulted from similar treatment of incubated unconjugated plasmid, no tumours were produced by a secondary round of transfections using DNA from this tumour. Selective PCR amplification of the human Ha-ras gene in extracted tumour DNA followed by sequencing demonstrated the presence of G-->T transversions either at the first or middle base of codon 12 in tumours resulting from transfection with the aflatoxin-B1-modified pECneo plasmid, but this was not detected in the single tumour resulting from transfection with the unmodified plasmid. Thus, although a mutation in the Ha-ras gene has not been reported for human primary hepatomas occurring in aflatoxin-exposed populations, metabolically activated aflatoxin B1 is capable of mutating this proto-oncogene to its oncogenic form in vitro. No mutations were observed in codon 61. It appears that, in contrast to the frequently reported G-->T transversions in codon 249 of the p53 gene in primary hepatomas in aflatoxin-exposed humans, the failure to detect Ha-ras mutations in these tumours is not due to an inability of aflatoxin B1 to activate this proto-oncogene. The G-->T transversions observed in this study contrast with the most frequent aflatoxin B1 in vivo induced mutations, G-->A transitions in the rat Ki-ras gene. Possible mechanisms for these differences are discussed.

3T3 Cells↗

PubMed1982

Synthesis of transfer RNA in rat liver after acute and chronic aflatoxin B1 administration.

Synthesis of rat liver tRNA following acute and chronic administration of aflatoxin B1 was compared to protein synthesis. Twenty hours after acute administration of aflatoxin B1 total RNA synthesis was inhibited by 91% and tRNA synthesis by 77% while protein synthesis as assayed in vitro was inhibited by 75%. In the chronic (long-term) experiment at 7, 18 and 30 weeks after administration of aflatoxin B1 no inhibition of total RNA and tRNA synthesis was observed but protein synthesis in the cell-free system was inhibited by 16%. Thus, the inhibitory effects on protein synthesis observed in the long-term experiments are not correlated with the inhibition of tRNA synthesis.

Aflatoxin B1↗